Market Place
Sourcing Support
BioRestorative Therapies Announces Collab with 203 Creates
07 Apr 2026 //
GLOBENEWSWIRE
BioRestorative Therapies Joins Be+Well Show in NYC, March 8-10
05 Mar 2026 //
GLOBENEWSWIRE
BioRestorative Announces Closing Of $5.0 Million Public Offering
13 Feb 2026 //
GLOBENEWSWIRE
BioRestorative Strengthens Commercial Leadership with Appointment
22 Oct 2025 //
GLOBENEWSWIRE
Biorestorative Therapies Joins 2025 Maxim Growth Summit
15 Oct 2025 //
GLOBENEWSWIRE
Biorestorative CEO Alstodt Interviewed On `The Big Biz Show`
07 Oct 2025 //
GLOBENEWSWIRE
BioRestorative Raises $1.09M in Registered Direct Offering
06 Oct 2025 //
GLOBENEWSWIRE
BioRestorative Therapies Q2 2025 Financial Results and Update
12 Aug 2025 //
GLOBENEWSWIRE
BioRestorative Therapies to Report Q2 2025 Financial Results
05 Aug 2025 //
GLOBENEWSWIRE
BioRestorative Therapies Reports Q1 2025 Results and Update
14 May 2025 //
GLOBENEWSWIRE
BioRestorative Therapies to Report Q1 2025 Results, Host Call
08 May 2025 //
GLOBENEWSWIRE
BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025
07 May 2025 //
GLOBENEWSWIRE
BioRestorative Joins Benzinga to Share Key Milestones
15 Apr 2025 //
GLOBENEWSWIRE
BioRestorative Receives Key New Patent for ThermoStem® Program
05 Dec 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Reports Q3 2024 Financial Results & Update
12 Nov 2024 //
GLOBENEWSWIRE
BioRestorative Receives Patent Allowance for ThermoStem® Program
31 Oct 2024 //
GLOBENEWSWIRE
BioRestorative`s Chief Scientist Named Editor Of Translational Medicine Journal
23 Jul 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Notice of Allowance for Patent Covering
27 Jun 2024 //
GLOBENEWSWIRE
BioRestorative Regains Compliance With Nasdaq Rule; Reports Q1 2024 Results
17 Jun 2024 //
GLOBENEWSWIRE
BioRestorative: Attending Jefferies 2024 Healthcare Conference
04 Jun 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
24 May 2024 //
GLOBENEWSWIRE
BioRestorative Partners With Cartessa, Enters $75B Aesthetics Market
15 May 2024 //
ACCESSWIRE
BioRestorative Therapies Provides First Quarter 2024 Business Update
14 May 2024 //
GLOBENEWSWIRE
BioRestorative, Cartessa Commercial Aesthetics Tech Deal
30 Apr 2024 //
GLOBENEWSWIRE
BioRestorative To Report Q1 2024 Results, Host Call On May 14
30 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Announces Filing of Form S-1 Statement to Reg for Common Stock
03 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
01 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
11 Mar 2024 //
GLOBENEWSWIRE
BioRestorative Announces Exercise of Warrants and Issuance of New Warrants
06 Feb 2024 //
GLOBENEWSWIRE
BioRestorative Receives a Notice of Allowance by USA Patent for Patent Related to Obesity Program
12 Dec 2023 //
GLOBENEWSWIRE
BioRestorative to Participate at ROTH MKM Healthcare Opportunities Conference
09 Oct 2023 //
GLOBENEWSWIRE
BioRestorative Announces Activation of Northwell Health in Phase 2 Trial
08 Sep 2023 //
GLOBENEWSWIRE
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
11 Jul 2023 //
GLOBENEWSWIRE
BioRestorative Therapies Receives Unanimous Recommendation from DSMB
27 Jun 2023 //
GLOBENEWSWIRE
BioRestorative to Participate in the Healthcare Virtual Conference
16 Jun 2023 //
GLOBENEWSWIRE
BioRestorative Announces Dosing Completion in Phase 2 Trial Targeting Chronic Lumbar Disc Disease
12 Jun 2023 //
GLOBENEWSWIRE
BioRestorative Therapies to attend the Jefferies 2023 Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
BioRestorative Receives License from New York State Department of Health
31 May 2023 //
GLOBENEWSWIRE
BioRestorative Receives Notice of Allowance by the Japanese Patent & Trademark
15 May 2023 //
GLOBENEWSWIRE
BioRestorative Therapies and Northwell Health Enter into Agreement
08 May 2023 //
GLOBENEWSWIRE
BioRestorative Therapies, Inc. to participate at the EF Hutton Global Conference
04 May 2023 //
GLOBENEWSWIRE
BioRestorative Therapies Receives Notice of Allowance by United States Patent
02 Mar 2023 //
GLOBENEWSWIRE
BioRestorative Announces Notice of Allowance by the European Patent Office
08 Feb 2023 //
GLOBENEWSWIRE
BioRestorative Announces SBIR Phase I Grant to Explore the Therapeutic Effects
06 Dec 2022 //
GLOBENEWSWIRE
BioRestorative Enters Agreement with Regenexx, Granting BRTX License Rights
05 Dec 2022 //
GLOBENEWSWIRE
BioRestorative to Participate at the RHK Capital Disruptive Growth Conference
29 Nov 2022 //
GLOBENEWSWIRE
BioRestorative CEO Lance Alstodt to be Interviewed on Famela
20 Oct 2022 //
GLOBENEWSWIRE
BioRestorative Therapies to Present at the Dawson James Securities 7th Small
28 Sep 2022 //
GLOBENEWSWIRE
BioRestorative Therapies to Participate in the Roth Inaugural Healthcare
27 Sep 2022 //
GLOBENEWSWIRE
BioRestorative Therapies to Present at the H.C. Wainwright 24th Annual GIC on
07 Sep 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Begins Enrollment in PII Trial for cLDD
30 Jun 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Trial Contract with Second Site for PII Trial
22 Jun 2022 //
GLOBENEWSWIRE
BioRestorative Announces Clinical Site Initiation for PII Trial to Treat cLDD
13 Jun 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Hosts Investigator Meeting for its BRTX-100 PII Trial
29 Apr 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Selects 10 Clinical Sites for PII Trial
18 Apr 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Shows cGMP Cell Manufacturing Facility Certification
04 Apr 2022 //
GLOBENEWSWIRE
BioRestorative says Research Collaboration with Professor Tore Bengtsson
10 Mar 2022 //
GLOBENEWSWIRE
BioRestorative Nabs Notice of Allowance on Key Patent for BRTX-100 Disc Program
16 Feb 2022 //
GLOBENEWSWIRE
BioRestorative Therapies to Ring Nasdaq Stock Market Closing Bell
07 Feb 2022 //
GLOBENEWSWIRE
